Finding. In worms, too much α-synuclein keeps the mitochondrial unfolded-protein response on and dopamine neurons die faster. Turning off ATFS-1, the UPRmt transcription factor, protects those neurons. A screen in that protected background found three genes the neurons still need: the H3K27me3 demethylases jmjd-1.2 and jmjd-3.1, and the K+ leak channel twk-14. Take any one of them away in dopamine neurons and the protection collapses. Chromatin and a resting-potential channel sit between mitochondrial stress signaling and α-synuclein toxicity.
Why this paper matters
UPRmt is often sold as uniformly helpful. Here chronic ATFS-1 activity is part of the problem. The screen then asks what else is holding the neurons up once that pathway is gone. Two histone demethylases and a KCNK-class channel is an unexpected protective triad, with named human orthologues.
What they actually measured
α-Syn DA-neuron degeneration, atfs-1(lf) protection, F3 screen, new nonsense alleles, neuron-targeted depletion restoring degeneration.
How to read the score
Low seventies. Clean genetic logic, mitochondrial-stress frame. Confidence is medium. Score 72.
What to do with it
If you model UPRmt, α-synuclein, or KDM7-family enzymes, pull the alleles and the neuron-specific RNAi. Do not treat ATFS-1 inhibition as a PD therapy. The directional implication is that chronic mitochondrial UPR can worsen α-synuclein toxicity, and that H3K27me3 demethylases and TWK-14 buffer the neuron when that UPR is off.